Aethlon Medical (AEMD) Notes Payables (2011 - 2019)

Aethlon Medical's (AEMD) quarterly Notes Payables came in at $892591.0 in Q2 2019, down 7.24% on a QoQ basis from $962301.0 in Q1 2019.

Aethlon Medical (AEMD) Notes Payables (2011 - 2019) Analysis & Trends

Aethlon Medical (AEMD) has 8 years of Notes Payables data on file, last reported at $892591.0 in Q2 2019.

Quarterly Notes Payables changed N/A year-over-year to $892591.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $892591.0 (changed N/A YoY) and the FY2019 annual result came in at $962301.0, changed N/A from the prior year.
Notes Payables declined to $892591.0 in Q2 2019, from $962301.0 in the prior quarter.
In the past five years, Notes Payables ranged from a high of $962301.0 in Q1 2019 to a low of $248367.0 in Q2 2015.
A 4-year average of $664870.4 and a median of $749203.0 in 2016 frame the typical range for Notes Payables.
Annual changes were most pronounced in 2015 — Notes Payables tumbled 36.32% — and 2016, when it surged 77.4%.
Tracing AEMD's Notes Payables over 4 years: stood at $434643.0 in 2015, then soared by 39.38% to $605815.0 in 2016, then jumped by 53.84% to $932014.0 in 2018, then dropped by 4.23% to $892591.0 in 2019.
The last three Notes Payables figures came in at $892591.0 (Q2 2019), $962301.0 (Q1 2019), and $932014.0 (Q4 2018), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn
10	Aethlon Medical	1.07 Mn	1.07 Mn	-

Download Data